Nurix Therapeutics

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies that modulate the ubiquitin-proteasome system to treat cancer and other serious diseases. They generate revenue through partnerships, licensing agreements, and the development of proprietary drug candidates. Founded in 2009 and headquartered in San Francisco, Nurix has established collaborations with major pharmaceutical companies like Gilead Sciences to advance their innovative therapeutic programs.

Recent Posts by Nurix Therapeutics

1-2 of 2